Semi-Supervised Deep Learning for Abnormality Classification in Retinal
  Images by Lecouat, Bruno et al.
Semi-Supervised Deep Learning for Abnormality
Classification in Retinal Images
Bruno Lecouat1 Ken Chang2 Chuan-Sheng Foo1 Balagopal Unnikrishnan
James M. Brown2 Houssam Zenati1 Andrew Beers2 Vijay Chandrasekhar1
Jayashree Kalpathy-Cramer2∗ Pavitra Krishnaswamy1∗
kalpathy@nmr.mgh.harvard.edu and pavitrak@i2r.a-star.edu.sg
1 Institute for Infocomm Research, A*STAR, Singapore
2 Athinoula A. Martinos Center for Biomedical Imaging,
Massachusetts General Hospital, Boston, MA, USA
Abstract
Supervised deep learning algorithms have enabled significant performance gains in
medical image classification tasks. But these methods rely on large labeled datasets
that require resource-intensive expert annotation. Semi-supervised generative
adversarial network (GAN) approaches offer a means to learn from limited labeled
data alongside larger unlabeled datasets, but have not been applied to discern fine-
scale, sparse or localized features that define medical abnormalities. To overcome
these limitations, we propose a patch-based semi-supervised learning approach and
evaluate performance on classification of diabetic retinopathy from funduscopic
images. Our semi-supervised approach achieves high AUC with just 10-20 labeled
training images, and outperforms the supervised baselines by upto 15% when less
than 30% of the training dataset is labeled. Further, our method implicitly enables
interpretation of the SSL predictions. As this approach enables good accuracy,
resolution and interpretability with lower annotation burden, it sets the pathway for
scalable applications of deep learning in clinical imaging.
1 Introduction
Deep learning is driving significant advances in automated analysis and interpretation of medical
images for applications spanning reconstruction, segmentation, diagnosis, prognosis and treatment
response assessment in radiology, dermatology, pathology, oncology and ophthalmology (5; 3;
6). Typically, medical imaging studies employ supervised convolutional neural networks (CNNs)
that require large datasets annotated by experts to obtain high predictive performance. In many
applications, this annotation burden is further exacerbated by the need for multiple annotations to
reduce labeling noise (6; 8).
Semi-supervised deep learning (SSL) algorithms that combine small labeled datasets with larger
unlabeled datasets offer a means to address these limitations. Recent works have explored SSL
approaches based on generative adversarial networks (GANs), and showed applicability to classifying
skin and heart disease (19; 10; 11). While these studies have demonstrated feasibility of the GAN
approach, they have been limited to low resolution images (32 × 32 to 110 × 110 pixels) and to
applications where clinically relevant features are present in large parts of the image. However, in
many cases, clinical image classification relies on fine features that are only visible in high resolution
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images and/or are sparsely distributed throughout the image. Further, the ability to interpret classifier
predictions would be desirable in practical scenarios.
To address these needs, we frame the semi-supervised medical image classification problem as one of
learning from very few labeled images with granular annotations, alongside a larger set of unlabeled
images. As an example, we consider patch-level annotations for the labeled set, and propose to
perform SSL at the patch level. We then aggregate predictions from individual patches of a given
image into an image-level classification without requiring additional annotation. As this approach
treats images as composites of finely labeled entities, it can overcome the resolution and interpretation
limitations encountered in previous works employing SSL using GANs for medical imaging and
computer vision applications (18; 15).
We demonstrate this approach on the task of classifying abnormalities in retinal fundoscopy images
obtained from Diabetic Retinopathy (DR) patients. DR patients are diagnosed based on the presence
of fine-scaled, sparse and localized microaneurysms, soft exudates, hard exudates, and hemorrhages,
which are hard to annotate. Therefore, computer-aided screening for early detection and intervention
(13) requires high-resolution images. We show that our GAN-based semi-supervised method can
provide accurate classification with far fewer labeled samples than CNN-based supervised methods.
Further, we demonstrate that our method can effectively detect fine-scale anomalies and classify
spatially sparse abnormalities in an interpretable manner. Finally, we discuss directions to enable
translation of semi-supervised deep learning methods for practical use in clinical imaging.
2 Patch-based Semi-Supervised Classification Approach
We propose a patch-based semi-supervised classification framework where high-resolution medical
images are divided into equal sized patches before being used for training or prediction with a
semi-supervised GAN (Figure 1). Predictions on individual patches are then aggregated to produce
an image-level prediction. Our patch-based approach enables visualization and localization of salient
predictive features by overlaying patch-level predictions onto the input image.
Image size  
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Sum patch-level
predictions 
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Figure 1: Overview of patch-based semi-supervised classification approach.
Semi-supervised GAN (SSL-GAN): GANs (4) are a class of deep generative neural network models
that have been successful in modeling distributions over natural images (14). A typical GAN consists
of a generator network G and discriminator network D. In the course of training a GAN on a set of
(unlabeled) images, the generator learns how to map a low-dimensional set of random variables Z to
generate images, while the discriminator learns how to differentiate between those generated images
and real images present in the training set.
We build upon the semi-supervised feature-matching GAN framework (16). This method extends
the discriminator D to determine the specific class of the image in addition to determining whether
the image is real or generated. Formally, suppose we are given a dataset of image patches I =
IL ∪ IU consisting of a labeled set IL = {(xi, yi)} and unlabeled set IU = {xi} of patches; here
xi and yi are the patches and labels (having K classes) respectively. Then, during training, we
simultaneously optimize D and G using stochastic gradient descent, minimizing loss functions LD
for the discriminator and LG for the generator. LD is the sum of a loss term on the labeled image
subset (Lsupervised) and the vanilla GAN loss (Lunsupervised) so that
LD = Lunsupervised + Lsupervised
Lsupervised = −E(x,y)∼IL [log pD(y|x, y < K + 1)]
Lunsupervised = −Ex∼I [log[1− pD(y = K + 1|x)]]− Ex∼G [log[pD(y = K + 1|x)]] .
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LG, the feature-matching loss designed to encourage generated patches to have similar features to
the real patches.
LG =
∥∥Ex∼I [h(x)]− Ez∼pz(z) [h(g(z))]∥∥1
Here, h(x) denotes activations on an intermediate layer of the discriminator. In our experiments, the
activation layer after the Networks in Networks (NiN) layers (9) was chosen as intermediate h(x).
As the generator and discriminator networks in (16) were developed for benchmark natural image
datasets, we adapted the networks to the larger image sizes and distinct image statistics of the retinal
funduscopy datasets (Experimental Setup, Supplement 1).
Image level predictions: At evaluation time, we applied the semi-supervised GAN to derive patch-
level predictions and then pooled these patch-level predictions to form an image-level abnormality
score: scorei =
∑64
j=1 σ(lij) where lij is the classifier logit of patch j in image i. If the image-level
abnormality score exceeds a threshold, the classifier predicts that the image is diseased.
3 Experimental setup
Dataset and Pre-processing: We evaluated our SSL-GAN approach on color retinal fundus images
from the IDRiD challenge dataset collected at an eye clinic located in Nanded, Maharashtra, India (12).
This dataset contains images from 249 patients (168 healthy, 81 DR). DR patients are diagnosed based
on the presence of microaneurysms, soft exudates, hard exudates, and hemorrhages in retinal fundus
photographs (6); the IDRiD dataset contains segmentation masks for each of these abnormalities.
We randomly split the dataset into Training (n=149), Validation (n=50), and Testing (n=50) cohorts.
We resized the original images to 1024× 1024 and normalized them by the maximum intensity value
in each image. We then subdivided the normalized image into non-overlapping 128× 128 patches
based on a uniform 8x8 grid. To determine patch-level labels, we combined segmentation masks
for each of the abnormalities into a single binary mask. Then, we labeled patches with 0 pixels
overlapping the mask as healthy; and denoted patches with at least 1 overlapping pixel as diseased. A
majority of the patches had very sparse disease features (< 3% of the patch overlapped abnormality
masks).
Baselines: We compared the semi-supervised approach (SSL-GAN) in the patch-based framework
against two supervised baselines: a shallow CNN with architecture similar to the GAN (ConvNet),
and a 34-layer residual network (ResNet34, (7). For both SSL-GAN and supervised baselines,
we employed the same method to aggregate patch-level predictions to produce an image-level
classification.
Model Training and Evaluation: The SSL-GAN uses limited labeled data and lots of unlabeled
data during training. We sampled labeled images randomly from the training cohort; and used
remaining images in the training cohort as unlabeled data. We evaluated the algorithm with different
ratios of labeled-to-unlabeled data in the training set. We report mean classification AUCs both at
the patch and image levels over 5 random samplings with the associated standard deviations. For
appropriate comparisons, we performed supervised baselines with only the limited labeled data
samples used in the SSL experiments, and repeated training with 5 different random seeds. We detail
model architectures and training hyperparameters in Supplement 1.
4 Results
Classification Performance as a Function of Annotation: We present the semi-supervised classi-
fication results, and benchmark against supervised deep learning baselines – both at the patch and
image levels. In particular, we vary the proportion of labeled data in the training set, and evaluate
how annotation relates to classification performance across the different methods.
Table 1: AUC of Semi-supervised vs. Supervised Learning: Patch-level Classification
Labeled/Total Images: 10/149 20/149 40/149 80/149 149/149
SSL-GAN (Patch) 75.8± 2.7 79.4± 4.9 81.7± 2.9 83.3± 1.1 84.5± 4.7
ConvNet (Patch) 68.3± 3.9 72.8± 2.4 77.3± 0.14 79.5± 1.8 79.6± 0.22
ResNet34 (Patch) 52.2± 23.0 61.5± 17.0 73.9± 10.8 81.2± 8.0 85.1± 2.6
At the patch-level, the SSL-GAN significantly outperforms the supervised baselines. We observe
that the SSL-GAN image-level predictions tend to have about 10% higher AUC than the associated
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Table 2: AUC of Semi-supervised vs. Supervised Learning: Image-Level Classification
Labeled/Total Images: 10/149 20/149 40/149 80/149 149/149
SSL-GAN (Image) 84.5± 11.5 89.0± 10.6 94.7± 3.3 98.5± 0.6 99.1± 0.34
ConvNet (Image) 71.1± 12.0 81.4± 0.57 87.4± 2.9 94.5± 0.16 97.8± 1.0
ResNet34 (Image) 71.3± 16.7 79.4± 15.3 80.5± 5.8 84.2± 2.0 98.9± 1.7
patch-level predictions (Table 1 vs. 2). For the final image-level predictions, the semi-supervised
classifier shows significant improvements over supervised baselines, even when less than 10% of the
training dataset is labeled. In particular, when less than 30% of the training dataset is labeled, the
SSL-GAN outperforms CNNs by upto 15%. We also performed comparisons to a 50-layer residual
network trained for direct classification on full-size images (Supplement 2).
Interpretation of Abnormality Predictions: To interpret the SSL classification results, we overlaid
the localized patch-level abnormality scores spatially onto the image; and smoothed the resulting
visualization with a Gaussian blur. Figure 2 shows some example testing results obtained from an
SSL-GAN trained with 20 labeled images. The predictions are clinically meaningful: qualitative
comparisons with ground truth segmentation masks suggest that the method can accurately detect
exudates and hemorrhages, although there are some misses at the peripheral patches. We quantitatively
compared the resulting localization masks against the ground truth annotations, and found that the
SSL-GAN had an AUC gain of 16.30% over the CNN baselines.
True PositiveTrue Negative True Positive False Positive
Figure 2: Exemplar test-set images with overlay of patch-based abnormality scores predicted by the
SSL-GAN. In each case, the image-level classification accuracy is indicated.
Taken together, these results suggest that our semi-supervised GAN approach can provide significant
improvements over supervised baselines, maintain classification accuracy with large reductions
in labeling burden, and enable localization for better interpretation of results. We performed a
preliminary test to explore how the models trained on the IDRiD data generalize to an independent
test on the Kaggle Diabetic Retinopathy dataset. The SSL-GAN had an AUC of 64% against 47%
on the supervised CNN baselines, suggesting that the semi-supervised models could exhibit greater
capacity to adapt and generalize to varying dataset, class distribution and cohort characteristics.
5 Discussion
We have proposed a patch-based approach to extend SSL with GANs to high-resolution scenarios
typical of medical applications. Our approach leverages granular annotations on a minimal dataset,
and offers an effective, efficient alternative to supervised approaches that require coarse annotation
for large datasets. To the best of our knowledge, this is the first report employing GANs for semi-
supervised classification of fine-scale sparse abnormalities in images. Further, as our semi-supervised
classifier produces patch-based predictions, it also implicitly provides a valuable means to interpret
the image-level classification results. As such, our work demonstrates that it is possible to use GAN-
based semi-supervised deep learning to concomitantly reduce annotation burden, obtain accurate
classifications, maintain desirable resolutions and enable interpretation of predictions. This has
implications for practical systems focused on scaling applications of deep learning in cross-sectional
and multi-dimensional clinical imaging applications.
Although we demonstrated feasibility on retinal image classification, our approach generalizes to
a range of classification tasks involving high spatial resolution images and/or sparse anomalous
features. Example applications include digital pathology with gigapixel whole-slide images (17),
cancer screening with cross-sectional CT/MRI (2) and severity grading in multiple sclerosis (1).
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Existing SSL methods have been developed on standard computer vision datasets wherein image
structure and composition vary significantly with the target labels. However, as medical images
typically have more structural similarity and greater redundancy amongst samples, there is need to
design new methods for these unique requirements.
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Appendices
A Architecture and Hyperparameters
The semi-supervised network architectures are detailed in Tables 3 and 4. Briefly, the discriminator
comprises a 10-layer convolutional neural network with dropout and weight normalization; and the
generator comprises a 5-layer convolutional neural network with batch normalization. For semi-
supervised learning and the associated CNN, we downsampled the patches to 32×32. We augmented
the data during training by performing random cropping and flipping of the input training images.
We used an exponential moving average of the parameters for inference on the testing set. We used
the validation datasets to determine the model hyper-parameters (Supplement Table 6). The hyper
parameters are maintained across all experiments. We will release our code in due course.
Table 3: Discriminator
conv-large DR
32×32×3 images
dropout, p = 0.2
3×3 conv. weightnorm 96 lReLU
3×3 conv. weightnorm 96 lReLU
3×3 conv. weightnorm 96 lReLU stride=2
dropout, p = 0.5
3×3 conv. weightnorm 192 lReLU
3×3 conv. weightnorm 192 lReLU
3×3 conv. weightnorm 192 lReLU stride=2
dropout, p = 0.5
3×3 conv. w-tnorm 192 lReLU pad=0 stride=2
3×3 conv. w-tnorm 192 lReLU pad=0 stride=2
NiN weightnorm 192 lReLU
NiN weightnorm 192 lReLU
global-pool
dense weightnorm 10
Table 4: Generator
DR
latent space 100 (uniform noise)
dense 6 × 6 × 512 batchnorm ReLU
5×5 conv.T 256 batchnorm ReLU stride=2
5×5 conv.T 128 batchnorm ReLU stride=2
5×5 conv.T 128 batchnorm ReLU stride=2
5×5 conv.T 3 weightnorm tanh stride=2
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Table 5: Hyperparameters resnet34
Hyper-parameter DR
Batch size 32
Optimizer ADAM (α = 1 ∗ 10−5β1 = 0.9)
Epoch early stopping with patience of 20
Loss binary crossentropy balanced class-weighting
Learning rate decay reduce LR to 10% of its value with a patience of 10
Augmentation 0-180 degree rotation, L-R flipping, U-D flipping0-30% horizontal shift, 0-30% vertical shift
Table 6: Hyperparameters semi-supervised GAN
Hyper-parameter DR
Epoch 1200
Batch size 100
Leaky ReLU slope 0.2
Exp. moving average decay 0.999
Learning rate decay linear to 0 after 1000 epochs
Optimizer ADAM (α = 3 ∗ 10−4, β1 = 0.5)
Weight initialization Isotropic gaussian (µ = 0, σ = 0.05)
Bias initialization Constant (0)
B Image Level Classification Results
We present AUCs obtained from a direct fully supervised image-level classification (Table 5). These
results serve as a baseline to assess how the use of finer patch-level annotations and aggregation of
patch-level predictions affects supervised image classification.
Table 7: AUC of Semisupervised vs. Supervised Learning: Direct Image-Level Classification
Labeled/Total Images 10/149 20/149 40/149 80/149 149/149
Pretrained (Image) 85.8± 20.0 98.2± 0.8 98.8± 1.0 99.2± 0.5 98.8.0± 0.8
ResNet50 (Image) 56.8± 15.8 65± 17.11 67.8± 15.4 76.4± 5.9 82.2± 4.0
We note that pre-training reuses weights from networks that are trained on general scene databases
(e.g., ImageNet, CIFAR-10), and produces good results even with low numbers of labeled images.
However, it must be noted that such workarounds carry the risk of neglecting critical clinical
information, reducing interpretability, and do not apply to common clinical scenarios involving
cross-sectional (3D) imaging or video data.
C Future Directions
Our approach enhances and adapts semi-supervised deep learning to the unique challenges of medical
datasets. Future work on the translational front will focus on moving towards practical retinal image
classification systems. On the methodological front, our study suggests directions towards improved
semi-supervised deep learning methods.
Retinal Image Classification: The current method still shows a number of false negatives at patch
level. Employing overlapping patches and/or other unsupervised mechanisms to pool patch-level
predictions for image-level classification might help to improve sensitivity. Further, we used con-
sensus labels as ground truth in this study, and will explore the effect of the inter-rater variability on
the semi-supervised learning process, especially as the number of labeled samples reduces. Finally,
we will investigate the effects of varying patch size, threshold to translate pixel-level labels into
patch-level labels, and benchmark SSL performance for these variations of finer labeling against the
naive coarse image-level labeling approach.
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Semi-Supervised Deep Learning Methods: One limitation of the present work is that there is no
theoretical guideline for the number of samples to label across the different classes or recommen-
dations for which samples to label. Future work should focus on actively informing the selection
of the labeled sample subsets. Further, developing capability to effectively “pre-train” GAN-based
semi-supervised models and evolving a consensus on comparisons between semi-supervised meth-
ods and supervised baselines will be necessary to ground practical translation studies for clinical
applications. Comparative evaluations across semi-supervised deep learning approaches and deeper
supervised CNNs for a range of medical image classification tasks are needed to address these issues
systematically.
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